Velsuckity

Quote


This product is a disaster and I bet the "anywhere but working" Anne and "totally clueless" Tricia get the boot. Knowing Pfizer, they will get promoted in a year and then parachuted out after that.
 
anonymous said:
that there is a better product with the same MOA that launched two years earlier into a crowded market.

This product will never make more than a hundred million a year. cost billions to buy.
Click to expand...

Better product? Have you talked to any KOLs about their opinion? Z has smaller deltas. If we rerandomized instead of a treat through, our remission numbers would be pushing 50%. Z just missed the mark on their crohns data. The door is wide open for Velsipity to dominate the oral market.
 
anonymous said:
Better product? Have you talked to any KOLs about their opinion? Z has smaller deltas. If we rerandomized instead of a treat through, our remission numbers would be pushing 50%. Z just missed the mark on their crohns data. The door is wide open for Velsipity to dominate the oral market.
Click to expand...

Where is the door? All I see is hundreds of reps, 6 months, and 50 patients.
 
anonymous said:
tricia couldnt girl boss her way with that DEI team to a successful launch. she will go the way of leslie. OUT of pfizer!
Click to expand...

This comment would be hilarious if it werent true. Unqualified diversity hires destroyed a billion dollar acquisition brand.

My account director already told us no payer coverage expected in 2024. If you are in Michigan or Minnesota there is no bridge program.

No hope.
 
Litfolo with a black box and small market and entrenched competitor from big brand company is making millions of dollars a week from their all girl marketing team and diversity sales team.

Maybe our VELSUCKITY team is just bad and also happen to be women. Maybe our payer team is even worse. They get coverage for bald kids but cant get us on formulary anywhere at all. What the effff!!!
 
The payer team walked away from 2nd line therapy with a major PBM out of hubris. They demanded 1st line parity. Not gonna happen when these plans make millions of $ on rebates with other companies. We have nothing to offer them to justify the 1st line status.
 
anonymous said:
The payer team walked away from 2nd line therapy with a major PBM out of hubris. They demanded 1st line parity. Not gonna happen when these plans make millions of $ on rebates with other companies. We have nothing to offer them to justify the 1st line status.
Click to expand...

I heard this in the derm thread but don’t believe it. It just is so unrealistic. They’d jump at second or even third line.
 
anonymous said:
Litfolo with a black box and small market and entrenched competitor from big brand company is making millions of dollars a week from their all girl marketing team and diversity sales team.

Maybe our VELSUCKITY team is just bad and also happen to be women. Maybe our payer team is even worse. They get coverage for bald kids but cant get us on formulary anywhere at all. What the effff!!!
Click to expand...

They have 70% coverage for alopecia while we have 0% for UC. It’s the same payer team. I don’t get it. My customers are interested but who is doing a medical exception when Zep exists??
 


Write your reply...
Top Bottom
Back
Quote